Graf Akcie BMRN (Biomarin Pharmaceutical Inc.). Diskuze k akciím BMRN. Aktuální informace BMRN.

Základní informace o společnosti Biomarin Pharmaceutical Inc. (Akcie BMRN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 14.1B
Hodnota podniku (EV) 14.28B
Tržby 1.917B
EBITDA 6.096M
Zisk 837.214M
Růst v tržbách Q/Q 16.81 %
Růst v tržbách Y/Y 3.76 %
P/E (Cena vůči ziskům) 16.70
Forward P/E -236.82
EV/Sales 7.45
EV/EBITDA 2,342.96
EV/EBIT N/A
PEG 2.77
Price/Sales 7.36
P/FCF 81.33
Price/Book 3.43
Účetní hodnota na akcii 22.46
Hotovost na akcii 5.83
FCF vůči ceně 1.23 %
Počet zaměstnanců 3,059
Tržba na zaměstnance 626.552k
Profit margin 46.18 %
Operating margin -3.34 %
Gross margin 71.82 %
EBIT margin -2.19 %
EBITDA margin 0.32 %
EPS - Zisk na akcii 4.62
EPS - Kvartální růst -143.75 %
EPS - Očekávaný růst příští rok -105.99 %
Return on assets 14.12 %
Return on equity 20.22 %
ROIC -0.25 %
ROCE -0.77 %
Dluhy/Equity 0.42
Čistý dluh/EBITDA -17.24
Current ratio 5.32
Quick Ratio 3.71
Volatilita 2.38
Beta 0.80
RSI 46.77
Cílová cena analytiků 109
Známka akcie (dle analytiků) 1.88
Insider ownership 0.57 %
Institutional ownership 97.21 %
Počet akcií 183.352M
Procento shortovaných akcií 7.47 %
Short ratio 11.16 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1999
Země United States

Finanční výsledky akcie BMRN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,704.048$1,491.212$1,313.646$1,116.854$889.895$749.284
Cost Of Goods Sold$359.466$315.264$241.786$209.62$152.008$122.267
Gross Profit$1,344.582$1,175.948$1,071.86$907.234$737.887$627.017
Research And Development Expenses$715.007$696.328$610.753$661.905$634.806$461.543
SG&A Expenses$680.924$604.353$554.336$476.593$402.271$302.156
Other Operating Income Or Expenses$25$50$125$-599.118$170.798$67.5
Operating Expenses$1,804.505$1,614.736$1,328.346$1,920.283$1,000.597$842.175
Operating Income$-100.457$-123.524$-14.7$-803.429$-110.702$-92.891
Total Non-Operating Income/Expense$5.646$-19.181$-21.175$-27.621$-44.022$-31.977
Pre-Tax Income$-94.811$-142.705$-35.875$-831.05$-154.724$-124.868
Income Taxes$-70.963$-65.494$81.167$-200.84$17.075$9.101
Income After Taxes$-23.848$-77.211$-117.042$-630.21$-171.799$-133.969
Other Income------
Income From Continuous Operations$-23.848$-77.211$-117.042$-630.21$-171.799$-133.969
Income From Discontinued Operations------
Net Income$-23.848$-77.211$-117.042$-630.21$-171.799$-133.969
EBITDA$2.843$-27.495$76.238$-705.217$-61.338$-39.809
EBIT$-100.457$-123.524$-14.7$-803.429$-110.702$-92.891
Basic Shares Outstanding179177174166160146
Shares Outstanding179177174166160146
Basic EPS$-0.13$-0.44$-0.67$-3.80$-1.07$-0.92
EPS - Earnings Per Share$-0.13$-0.44$-0.67$-3.81$-1.07$-0.92
# 2020 2019 2018 2017 2016 2015
Current Ratio2.08273.92982.70313.23642.44615.9288
Long-term Debt / Capital0.13470.21860.22460.19280.21620.2962
Debt/Equity Ratio0.27160.27980.41820.2470.27590.4208
Gross Margin78.905278.858581.594381.231282.918483.6822
Operating Margin-5.8952-8.2835-1.119-71.9368-12.4399-12.3973
EBIT Margin-5.8952-8.2835-1.119-71.9368-12.4399-12.3973
EBITDA Margin0.1668-1.84385.8035-63.1432-6.8927-5.3129
Pre-Tax Profit Margin-5.5639-9.5697-2.7309-74.4099-17.3868-16.665
Net Profit Margin-1.3995-5.1777-8.9097-56.4273-19.3055-17.8796
Asset Turnover0.36330.33680.28350.27760.23860.3027
Inventory Turnover Ratio0.52840.59390.50820.59030.55950.613
Receiveable Turnover4.51524.35225.02615.18795.39465.1864
Days Sales In Receivables80.838483.865472.62170.355867.659770.3769
ROE - Return On Equity-0.7638-2.6015-4.1672-22.7819-7.1558-8.7682
Return On Tangible Equity-0.966-3.3878-5.5891-31.2689-11.304-10.1718
ROA - Return On Assets-0.5085-1.744-2.5262-15.6625-4.6067-5.4121
ROI - Return On Investment-0.6609-2.0327-3.2313-18.3894-5.6086-6.1714
Book Value Per Share17.362216.650215.972516.022614.863510.2479
Operating Cash Flow Per Share0.15560.16421.32050.001-0.8905-0.065
Free Cash Flow Per Share0.16130.49051.07110.5309-1.51320.4541

Porovnání s konkurencí: Akcie BMRN

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
BMRN 16.70 2.77 3.76 % -105.99 % 20.22 % 3.43 46.18 %
Akcie ALXN 58.49 1.17 18.24 % 7.07 % 4.43 % 3.46 9.94 %
Akcie ESPR 0.00 N/A -71.25 % -9.12 % 196.42 % -2.95 -63.09 %
Akcie FOLD N/A 8.91 24.18 % -28.00 % -94.19 % 9.43 -106.12 %
Akcie CPRX 8.79 N/A 5.96 % -75.61 % 43.02 % 3.86 62.97 %
Akcie RARE N/A N/A 125.44 % 23.01 % -36.54 % 4.77 -68.84 %
Akcie SGMO N/A 0.47 23.58 % 3,300.00 % -27.95 % 2.54 -102.37 %
Akcie SGMO N/A 0.47 23.58 % 3,300.00 % -27.95 % 2.54 -102.37 %

Nedávné obchody insiderů: Akcie BMRN

Jméno Obchod Cena Objem
Henry J Fuchs
President, Worldwide R, and D
Option
20 Jul 2020
$65.97 $8,337,882
Michael G Grey
Director
Option
3 Aug 2020
$26.49 $66,225
David E I Pyott
Director
Nákup
31 Aug 2020
$78.26 $1,001,728
Elaine J Heron
Director
Option
7 Oct 2020
$26.49 $397,350
Jeffrey Robert Ajer
EVP and Chief Commercial Officer
Prodej
14 Oct 2020
$79.91 $169,489
Jean Jacques Bienaime
Chief Executive Officer
Option
27 Jan 2021
$26.49 $220,741
Jean Jacques Bienaime
Chief Executive Officer
Option
28 Jan 2021
$26.49 $441,509
V Bryan Lawlis
Director
Option
16 Feb 2021
$26.49 $198,675
Jean Jacques Bienaime
Chief Executive Officer
Option
17 Feb 2021
$26.49 $211,920
Jean Jacques Bienaime
Chief Executive Officer
Option
18 Feb 2021
$26.49 $185,430
Jean Jacques Bienaime
Chief Executive Officer
Option
19 Feb 2021
$26.49 $185,430

Diskuze k akciím BMRN